Home Search
drug development - search results
If you're not happy with the results, please do another search
A simple prescription for healing chronic disease
Dr Shireen Kassam MBBS, FRCPath, PhD, dipIBLM, Founder and Director of Plant-Based Health Professionals UK, explains a simple prescription for health as a remedy to chronic disease.
From insulin to immunotherapy: A century of discovery
Dr Faye Riley, Senior Research Communications Officer at Diabetes UK, highlights how immunotherapy is raising hopes for the next big breakthrough in type 1 diabetes.
How global evidence can improve outcomes for spinal patients
Everard Munting, President of EUROSPINE, explains why sharing knowledge about spinal treatments on a global scale is the most effective way to develop best practice and enable early interventions.
Environment: A natural remedy for mental ill-health
Jennifer Oroilidis from Mental Health Europe probes why the environment is a natural remedy for mental ill-health.
How valuable are randomised controlled trials in reproductive medicine?
Professor Darren Griffin reflects on how patients in fertility clinics should interpret the scientific evidence base when even the experts can’t seem to agree.
Bharat Biotech COVID vaccine shows 81% efficacy at Phase Three
The Bharat Biotech COVID vaccine, COVAXIN, appears to be 81% efficient against the virus in Phase Three of clinical trials.
Huntington’s disease: Present concern & therapeutic view
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, describes the present concern and future therapeutic perspective on Huntington’s disease.
FDA reveals that Johnson & Johnson vaccine is 86% effective
New documents from the FDA show that the Johnson & Johnson vaccine appears to be 86% effective against COVID-19 - signalling that it will soon be approved in the US.
The UK’s legalisation of medicinal cannabis
David Hardstaff of BCL’s Cannabis Law & Regulatory team considers the success of the UK’s legalisation of medicinal cannabis products.
The promises and challenges of biomodifying technologies for the UK
Michael Morrison, Senior Researcher in Social Science at the Centre for Health, Law and Emerging Technologies (HeLEX), University of Oxford, sheds light on the promises as well as biomodifying technologies for the UK.
Scientists use machine learning to identify likelihood of severe COVID
The research team believe that some people have a genetic predisposition that increases likelihood of severe COVID, which may be crucial to understanding how mutations could change outcomes.
Pfizer vaccine can still prevent death from the South African mutation
The Pfizer and BioNTech vaccine appears to be significantly less efficient against the South African mutation, but can still stop hosts from experiencing severe COVID and dying from the virus.
Commission launches “HERA Incubator” project to fight COVID mutations
The European Commission today (17 February) launched the "HERA Incubator", as both a "blueprint" for long-term health emergencies and a way to stop COVID-19 mutations.
70% of available COVID vaccines in 2021 have been pre-ordered
Currently, 16% of the global population have pre-ordered 70% of available COVID vaccines in 2021 - a group of virus experts now warn that COVID will keep evolving unless low income countries can access vaccines.
How will everyone benefit if WTO members sign the TRIPS COVID-19 waiver?
Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, explains how the TRIPS COVID-19 waiver rejected by the WTO could ramp up global vaccine production.
Novavax vaccine is 85.6% efficient against UK COVID mutation
Phase Three data from the UK trial shows that Novavax still works powerfully against the UK mutation, with a less intense impact on the South African mutation at 60%.
European Commission to create “transparency mechanism” for vaccine exports
In response to the AstraZeneca feud, EU officials are creating a "transparency mechanism" for vaccine exports - which would indirectly hold companies accountable for fulfilling their agreed contracts.
Veganism and women’s healthcare: Contraceptive options for vegans
Dr Deborah Lee, Dr Fox Online Pharmacy, considers the contraceptive options available for vegans and the benefits and risks it can have on women's health.
Kim Schleppegrell Skaue joins Oils By Simpson: Their mission to promote natural medicine
Read on to find out more about Oils By Simpson, Kim Schleppegrell Skaue, and their joint mission to encourage natural medicine use worldwide.
The beginning of the end for Type 1 diabetes: A new view from immunotherapy...
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces ImotopesTM a cutting-edge immunotherapy science with an excellent safety profile that could cure Type 1 diabetes or drastically change treatment options.
